Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity.
about
Lipopolysaccharide endotoxinsOuter membrane vesicles as platform vaccine technologyHow the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis VaccinesNaturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathyHigh yield production process for Shigella outer membrane particlesConformational epitopes recognized by protective anti-neisserial surface protein A antibodies.Recent Progress in the Prevention of Serogroup B Meningococcal Disease.Intracellular survival of Neisseria gonorrhoeae in male urethral epithelial cells: importance of a hexaacyl lipid ACationic antimicrobial peptide resistance in Neisseria meningitidis.A triple mutant of Escherichia coli lacking secondary acyl chains on lipid A.Expression of a Porphyromonas gingivalis lipid A palmitylacyltransferase in Escherichia coli yields a chimeric lipid A with altered ability to stimulate interleukin-8 secretion.Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria.Effect of gonococcal lipooligosaccharide variation on human monocytic cytokine profileProfiles of structural heterogeneity in native lipooligosaccharides of Neisseria and cytokine inductionNatural phosphoryl and acyl variants of lipid A from Neisseria meningitidis strain 89I differentially induce tumor necrosis factor-alpha in human monocytesVirulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutantsReview of meningococcal group B vaccines.Agonistic and antagonistic properties of a Rhizobium sin-1 lipid A modified by an ether-linked lipid.Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activityInvolvement of the Escherichia coli O157:H7(pO157) ecf operon and lipid A myristoyl transferase activity in bacterial survival in the bovine gastrointestinal tract and bacterial persistence in farm water troughs.The transcriptional repressor FarR is not involved in meningococcal fatty acid resistance mediated by the FarAB efflux pump and dependent on lipopolysaccharide structure.The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease.The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal diseaseMeningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from AfricaDifferential induction of innate immune responses by synthetic lipid a derivativesModulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutantsNonclinical vaccine safety evaluation: advantages of continuous temperature monitoring using abdominally implanted data loggers.The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.LOS oligosaccharide modification enhances dendritic cell responses to meningococcal native outer membrane vesicles expressing a non-toxic lipid APleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens.Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria.Prevalence and clinical course in invasive infections with meningococcal endotoxin variants.Cysteine depletion causes oxidative stress and triggers outer membrane vesicle release by Neisseria meningitidis; implications for vaccine developmentThe msbB mutant of Neisseria meningitidis strain NMB has a defect in lipooligosaccharide assembly and transport to the outer membrane.Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathwaysImproved production process for native outer membrane vesicle vaccine against Neisseria meningitidis.Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys.A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccinesDifferential role of lipooligosaccharide of Neisseria meningitidis in virulence and inflammatory response during respiratory infection in mice.
P2860
Q24650970-F21F8349-A3D6-40B5-82EE-84131CFDA459Q26766539-9263DB91-E61C-499B-B01D-37704D09ABBFQ26782340-993D369A-0F73-4C55-AB8C-BE911A19D014Q28475336-DFCCDAEC-8635-4F1A-97D1-624AE3B09F8FQ28728768-2448F482-6BAA-40FC-99B1-4C74408646E6Q30164390-2627122D-7D29-4E5E-B0C8-A7800E7288CFQ30235040-C79D5B03-2FC0-4974-BEE0-2C42957B59CEQ30799516-DFABD8E7-DB69-46AE-ABBD-4A5BEC4A041EQ30857151-2A975C8B-6213-47EA-B125-FF1ABB7EEFD9Q31037616-56CAFF02-863F-4373-9541-8A5D07FAFF5FQ33230005-09709588-9E9F-4F7B-9AC3-8B1897ECA1E8Q33250412-849C399A-3B81-4775-878F-144DF794F79CQ33270547-01EBE57C-5A81-4C6B-81CC-234C14A4E52AQ33373636-E32BDC56-6EDD-4948-AC9B-B44964677A0AQ33468766-947E7341-F9BF-436A-856F-767EB0B4EDB5Q33557800-52EE4472-B1E2-4272-853E-875D7B79677BQ33646965-79649F87-D36C-4B90-AEBA-C425CDC3EFF1Q33696686-ADF3E85A-3CF4-42C4-885D-509CF77B5E6CQ33768763-146C5E22-3045-4513-94B8-A66600A08667Q33769305-549A7658-CD4C-45FD-BAA4-64C8950F4F3BQ33847702-8DFA9735-25B6-4E85-BA45-B2FEAD4FBD74Q33963083-595F505E-F93B-423B-A3E6-FADC7A322861Q34033179-8E70E61B-C4A9-45DE-8D08-D211465091A0Q34039044-2BE21623-7230-466C-B1EE-D36077B03B45Q34121591-56F684AB-50F2-44FE-869C-DCBAEB61A26CQ34138990-50896B24-6DBD-434E-9747-8F295AA24A7EQ34191062-3690D284-4B7B-4FF6-AF3F-E85E952D41A2Q34270429-9A906738-CA43-4A16-8BD6-DB29738FCD4AQ34376049-21B45294-A64D-43CD-AFE1-055816825192Q34394184-1F75A49E-9290-4C63-BF4C-59D8FE0D96D4Q34450073-F7014C19-BEBB-4F39-A8D1-8B5FB5FF66B7Q34499619-C4A4B862-74DA-4836-BB3A-1E3F7F49BE6AQ34571107-B7AFB9F5-1DA4-4FFB-BE25-6246334AE801Q34581610-2E9DD521-D2B7-43E2-B8BE-E433963E3868Q34690369-5452F1A3-318A-4BBB-B1BE-D87A904101B9Q34761285-E06BEF58-CF0C-439F-A776-3543F313D2E8Q34783257-A7108BA1-E336-4E9A-9C2A-9719CE7C657DQ35043042-D86ECA44-4730-499B-BFAB-AD90BB78BCCEQ35066132-EC4A227D-1B09-4E11-BD01-1F6E72992D93Q35073946-8BA7B451-7B87-4166-B273-7DA9F3C30871
P2860
Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Modification of lipid A biosyn ...... xicity, and adjuvant activity.
@ast
Modification of lipid A biosyn ...... xicity, and adjuvant activity.
@en
Modification of lipid A biosyn ...... xicity, and adjuvant activity.
@nl
type
label
Modification of lipid A biosyn ...... xicity, and adjuvant activity.
@ast
Modification of lipid A biosyn ...... xicity, and adjuvant activity.
@en
Modification of lipid A biosyn ...... xicity, and adjuvant activity.
@nl
prefLabel
Modification of lipid A biosyn ...... xicity, and adjuvant activity.
@ast
Modification of lipid A biosyn ...... xicity, and adjuvant activity.
@en
Modification of lipid A biosyn ...... xicity, and adjuvant activity.
@nl
P2093
P2860
P1476
Modification of lipid A biosyn ...... xicity, and adjuvant activity.
@en
P2093
H J Hamstra
J ten Hove
L van Alphen
P van der Ley
P2860
P304
P356
10.1128/IAI.69.10.5981-5990.2001
P407
P577
2001-10-01T00:00:00Z